---
title: "GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/449da0ea-7ac0-5659-8339-4d96ea0c7e09
json: https://whiteintel.dev/api/public/dossier/449da0ea-7ac0-5659-8339-4d96ea0c7e09
identifier: oo:GB-COH-08283186
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08283186`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/449da0ea-7ac0-5659-8339-4d96ea0c7e09  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/449da0ea-7ac0-5659-8339-4d96ea0c7e09  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED** — GLEIF · `lei:549300X3MLVYJEQN4J15` — https://whiteintel.dev/entity/6ee4003e-fa36-55ba-97ea-c7846fa7ca57

## Ownership & control

### Owners / controllers

- **Glaxo Group Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340

### UBO chain (walk to the ultimate owner)

A **15-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08283186`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2012-11-06
- **Registered office:** Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
- **SIC:** 64209

### Officers

- EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED — corporate secretary · appointed 2012-11-06
- BARCELO IGLESIAS, Cristina — director · British · appointed 2024-09-23
- FENT, Anna Mary Harcourt — director · British · appointed 2025-07-10
- GURUNLU RUSS, Demet — director · Turkish · appointed 2024-06-25
- RIVERS, Graham Paul — director · British · appointed 2023-07-18
- WALKER, Adam — director · British · appointed 2013-03-28
- EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED — corporate director · appointed 2012-11-06
- [GLAXO GROUP LIMITED](https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340) — corporate director · appointed 2012-11-06
- ANDERSON, Jill Dawn — director · British · appointed 2023-03-01 · resigned 2024-06-25
- ANDRIES, Jerome Charles Maurice — director · French · appointed 2017-10-01 · resigned 2023-03-01
- BLACKBURN, Paul Frederick — director · British · appointed 2012-11-06 · resigned 2016-02-01
- DINGEMANS, Simon Paul — director · British · appointed 2012-11-06 · resigned 2019-05-01
- LA CORTE, Luigi Felice — director · Italian · appointed 2015-04-20 · resigned 2017-09-30
- MACFARLANE, Fraser Gemmell — director · British · appointed 2013-03-28 · resigned 2016-11-01
- PRIESTMAN, Kate Sophie — director · British · appointed 2016-12-09 · resigned 2022-10-28
- REINAUD, Gregory Maxime — director · British · appointed 2024-01-30 · resigned 2024-07-24
- REYNOLDS, Jemma-Louise — director · British · appointed 2024-04-04 · resigned 2025-06-27
- SHAMSI, Ziba, Dr — director · British · appointed 2022-10-28 · resigned 2023-09-13
- WHEATCROFT, James Russell — director · British · appointed 2019-07-01 · resigned 2023-07-18

### Beneficial owners (Persons with Significant Control)

- [Glaxo Group Limited](https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08283186
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08283186

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED**. Human view: https://whiteintel.dev/entity/449da0ea-7ac0-5659-8339-4d96ea0c7e09 · Structured JSON: https://whiteintel.dev/api/public/dossier/449da0ea-7ac0-5659-8339-4d96ea0c7e09._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._